Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aspen Aerogels Announces Amendment to MidCap Credit Facility
-
Vine Hill Capital Investment Corp. II Announces Pricing of Upsized $200 Million Initial Public Offering
-
CPABC: Kootenay labour market shows cracks as unemployment rises
-
LACAHSA Board Approves $11.4M for Emergency Rental Assistance Funding, Bringing Total Measure A Prevention Investments to $29.5M in 2025
-
Future Mineral Announces Options Grant
-
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
-
Executive Chairman of Unisync Announces Acquisition of Shares
-
Avanza Capital Proudly Announces Attorney Anthony Varbero’s Appointment to New York City Bar Association’s Structured Finance Committee
-
Repurchased own ordinary shares reached 5% of Tenaris’s voting rights; Tenaris’s controlling shareholder files amendment to Schedule 13D
-
Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc.
-
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of November 2025
-
Talisker Reducing Bralorne Mine to Critical Staff due to Atmospheric River Event in Southern British Columbia
-
Banco Itaú Chile Files Material Event Notice announcing the appointment of Director
-
Debt Restructure Leverages Enhanced Liquidity
-
Northeast Bank Announces Significant Loan Purchase Volume
-
Ninepoint Doubles Target Yield on Energy Income Fund (NRGI) to 14%*
-
Talen Energy Reports PJM Auction Results for the 2027/2028 Planning Year
-
RYVYL Announces Stockholder Approval of Annual Meeting Proposals; Reverse Stock Split Process Commences to Remedy Nasdaq Delisting Notice
-
Chicago Snowballs Announce Elite Leadership Team, Season Opener, Naming Contest, and New-Year Tryouts for Pro Baseball’s First Co‑Ed Sportstainment Offering
-
Canadian Premium Sand Inc. Provides Corporate Update, Announces Extension of Convertible Debenture Maturity Date and Fiscal Year End 2025 Results
-
ROHM’s Flexible Brushed DC Motor Driver ICs for a Wide Range of Applications
-
Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
-
DataCT Selected as Independent Administrator of the U.S. Consolidated Tape Plan
-
Boot Barn Opens at Marketplace at Seminole Towne Center
-
Quantify Funds to Close STKd ETFs APED, SPCY, and ZIPP
-
Defiance ETFs Announces Closure of JPX, XPM, and VIXI Funds
-
Enerpac Tool Group Reports First Quarter Fiscal 2026 Results
-
NFI Announces CEO Transition
-
Capital Power Announces Conversion Results for Its Preferred Shares (Series 1)
-
CISO Global Books Over $1.1M in CHECKLIGHT® Software Sales -
-
Rivalry Reports Record Ontario Performance
-
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
-
Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson
-
Winnebago Industries Board of Directors names John Murabito as chair; Declares quarterly cash dividend
-
Guardforce AI Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification Letter
-
Nevada Titan Project Exploration Update, Magnetic Survey Confirmation – 8 Targets Identified.
-
Boumarang, Inc. Files S-1 Registration Statement with the U.S. Securities and Exchange Commission
-
CVB Financial Corp. and Heritage Commerce Corp Announce Agreement to Merge
-
OFA Group Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
-
Voting Rights and Shares Capital of the Company
-
BRT Apartments Corp. Completes Debt Refinancings
-
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
-
Methode Electronics’ Board Approves Dividend
-
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Great Southern Bancorp, Inc. announces quarterly dividend of $0.43 per common share
-
Hudson Technologies Announces Accretive Acquisition of Refrigerants Inc.
-
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
-
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
-
Parks! America Authorizes Share Repurchase Program
-
Haoxin Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid-Price Requirement

